In this study, we want to see if a new type of medicine for lung cancer treatment is better than the usual treatments. We are curious if this new medicine could improve things for people with lung cancer. This will help us understand if the new medicine will treat people better or faster.
Thank you for your interest, but this study will start enrolling soon.
North Carolina (Statewide)
Brendan McNulty
UNC Hospitals - Rex
Clinical or Medical
Interventional
Cancer (Lung)
24-0796
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
